RxDoctor Payments Data

Karen Moon, DPM

Podiatrist · Decatur, GANPI 1417458357

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Stryker at 43.9% of the total. Among podiatrist clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,951in general payments, 2019–2025

Across 198 payments — averaging $65.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Smith+Nephew$3K
  • Reel Surgical, Inc.$1K
  • Paragon 28, Inc.$1K
  • Amgen$380
  • Arthrex$148
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$5,56843%
  • Food & beverage$6,16548%
  • Education$1,2189%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,951 in reported general payments places this provider in the 90th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$135,822
Medicare patients
424
Services billed
2,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole12$17,537
EliquisApixaban11$6,660
Ciclopirox231$5,866
Diclofenac Sodium56$1,278
Ketoconazole58$932
Gabapentin64$744
Ammonium Lactate38$709
Pregabalin42$612
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$448
Nystatin29$354
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$269
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$230
Methylprednisolone37$223
Allopurinol24$186
Mupirocin19$183

Paid to pharmacies, not to this prescriber.

Other podiatrist in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →